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Abstract
Background: HIV prevention continues to be problematic in the UK, as it does globally. The UK Department of
Health has a strategic direction with greater focus on prevention as part of its World Class Commissioning
Programme. There is a need for targeted evidence-based prevention initiatives. This is an exploratory study to
develop an evidence mapping tool in the form of a matrix: this will be used to identify important gaps in
contemporary HIV prevention evidence relevant to the UK. It has the potential to aid prioritisation in future
research.
Methods: Categories for prevention and risk groups were developed for HIV prevention in consultation with
external experts. These were used as axes on a matrix tool to map evidence. Systematic searches for publications
on HIV prevention were undertaken using electronic databases for primary and secondary research undertaken
mainly in UK, USA, Canada, Australia and New Zealand, 2006-9. Each publication was screened for inclusion then
coded. The risk groups and prevention areas in each paper were counted: several publications addressed multiple
risk groups. The counts were exported to the matrix and clearly illustrate the concentrations and gaps of literature
in HIV prevention.
Results: 716 systematic reviews, randomised control trials and other primary research met the inclusion criteria for
HIV prevention. The matrix identified several under researched areas in HIV prevention.
Conclusions: This is the first categorisation system for HIV prevention and the matrix is a novel tool for evidence
mapping. Some important yet under-researched areas have been identified in HIV prevention evidence: identifying
the undiagnosed population; international adaptation; education; intervention combinations; transgender; sex-
workers; heterosexuals and older age groups.
Other research recommendations: develop the classification system further and investigate transferability of the
matrix to other prevention areas; evidence syntheses may be appropriate in areas dense with research; have
studies with positive findings been translated to practice?
The authors of this study invite research suggestions relating to the evidence gaps identified within remits of
Public Health or any appropriate NETSCC programme.
Follow the ‘Suggest Research’ links from:
http://www.netscc.ac.uk/. Enter - HIVProject - in optional ID for HTA or in first information box for other
programmes.
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HIV/AIDS persists as a major global health priority with
the number of people living with HIV continuing to
increase[1]. A report from the Global HIV Prevention
Working Group, a panel of leading AIDS experts,
warned that prevention efforts are not keeping pace
w i t ht h eg a i n sb e i n gm a d ei nt r e a t i n gp e o p l ei n f e c t e d
with HIV[2]. Revitalised global action is required for
HIV prevention that supports a combination of beha-
vioural, structural, and biomedical approaches[3].
In the UK 6,630 people were newly diagnosed as HIV-
infected in 2009; half were diagnosed late in infection
progression; approximately 22,000 are living with HIV
but remain undiagnosed (from unlinked anonymous
testing)[4]. Although new diagnoses appear to have
declined slightly in recent years this reflects undiagnosed
infection and diagnoses made abroad[5]. Undiagnosed
infection presents two major problems: i) unaware
onward transmission of HIV to others, ii) complications
in presentation and treatment when late stage HIV is
detected.
The scale and nature of sexual ill health and inequal-
ities in England are of concern to policy makers[6] and
consideration is currently being given to key action
points in the national Sexual Health Strategy expected
in 2011. The UK Department of Health has set the stra-
tegic direction for delivering healthcare with a greater
focus on prevention as part of its World Class Commis-
sioning Programme[7]. This includes recognition of the
long term cost effectiveness of prevention strategies and
the need to prioritise prevention to ensure viability of
the NHS in the long term. There is potential for the
methods outlined in this study to contribute to this aim
through focused research directions.
Evidence mapping can make a positive contribution to
policy agenda, with several research and policy gaps
being fed into existing prioritisation channels: this was a
concluding point from the Specialty Mapping Pilot by J.
Shepherd in 2007[8]. It is one of the few published
examples of innovative methodology to identify and
prioritise topics for HTA and it concludes by recom-
mending specialty mapping in other topic areas with
on-going evaluation: these points were the catalyst for
our study.
This study began on the premise that HIV prevention
is an area in need of novel evidence-based interventions
and that important yet under-researched areas within
HIV prevention exist: these could be identified through
thematic categorisation of the many possible combina-
tions of risk groups and prevention related activities.
We therefore devised a categorisation system for HIV
prevention and piloted a matrix tool to identify gaps
amongst the many contemporary studies on HIV
prevention from countries with possible relation to HIV
in the UK.
Methods
A literature scoping exercise was undertaken to identify
existing methodologies for conducting this work. The
closest appropriate were the Global Evidence Mapping
Initiative[9] and the Speciality Mapping Pilot [8]. These
were discarded, however, because both were more suited
to treatment care pathways than prevention. A new
matrix system for mapping evidence was developed to
collate publications into groups and combinations of
prevention related activities, risk groups and study types.
This was not an evidence synthesis and restricted
resources did not allow for quality appraisal of the stu-
dies beyond mapping according to hierarchy of
evidence.
Development of the matrix
Four external experts were consulted and participated in
the proposed classifications. These classifications repre-
sent important structural, contextual, behavioural, bio-
medical, service approaches, risk groups and
combinations of these (see Additional file 1). There are
important areas of research such as epidemiology that
require investigation before interventions can be
designed. A pilot was conducted on 100 publications to
assess the robustness of the matrix and adjustments
made accordingly.
Publication searches
A search was made of the NIHR HTA programme
Access databases (PROMIS) using the key term ‘HIV’
from inception in 1995 to March 2009. All topics identi-
fied and screened for being HIV prevention specific
were eligible for inclusion. This longer time period was
searched to provide additional internal audit, but
research prior to 2006 was later excluded to match the
time period of this study. A systematic search of major
electronic databases including MEDLINE, MEDLINE In-
Process, EMBASE, and Health Management Information
Consortium (all Ovid) and the Cochrane Library were
then searched using a carefully designed and tested
search strategy (see Additional file 2). Primary research
results were geographically filtered to studies undertaken
in the UK, USA, Canada, Australia and New Zealand.
Filtering by study location is liable to indexer error and
bias. We were primarily interested in HIV prevention in
the UK but USA publications were included as their
vast research programme is a source of evidence for
many other western countries. Canada, Australia, and
New Zealand were included as other English speaking,
developed countries with similar HIV epidemic and
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searched a grey literature database for NHS reports.
Published studies were searched from 2006 to July
2009 as HIV is a rapidly changing area of health and
contemporary evidence was deemed more useful in this
exploration of the matrix. Due to the time and resource
constraints the searches were limited to English lan-
guage only, which is considered an acceptable limitation
under such circumstances[10,11].
Inclusion/Exclusion criteria
Inclusions
Any study where the stated aim is to investigate HIV pre-
vention through epidemiology, policy, methods or var-
ious interventions; studies which aim to reduce
infectivity of HIV positive people by reducing viral load
(VL) through treatment adherence and reducing treat-
ment resistance; studies which investigate behavioural
and social factors stated to relate to risk of HIV infection;
English speaking countries only; studies from UK, USA,
Canada, Australia and New Zealand; publication dates
2006-2009 inclusive; systematic reviews, randomised con-
trolled trials and other primary research of high quality
(hierarchy of evidence) - case-controls, surveys, cohorts.
Exclusions
Studies which explore merits of HIV treatments but are
n o ts t a t e dt ob ec o n c e r n e dw i t hr e d u c i n gv i r a ll o a d
(VL)/infectivity to others e.g. side effects; depression/
stress studies that do not mention links to risk of trans-
mission or reduction of VL; studies that relate to HIV
b u ta r en o ts t a t e dt ob ec o n c e r n e dw i t hr i s ko ft r a n s -
mission e.g. relationships with children; primary
research of low quality (hierarchy of evidence) - case
studies, expert opinion, anecdotal evidence, narrative
reviews.
Search results, coding and quality assurance
Search results were downloaded to three electronic
Reference Manager (version 11) databases according to
study types: systematic reviews; randomised controlled
trials; other primary research (prospective/retrospective
cohort studies, surveys, case-controls, but not case ser-
ies). Each publication was screened for study type, date
of publication, geographical area and if actually HIV
prevention (see Inc/Exc criteria above). Included studies
were screened against definitions (Additional file 1) and
coded/counted accordingly. Many publications focused
on more than one risk group, therefore achieved more
counts e.g. A behavioural intervention for young,
socially excluded drug-users counted 1 in each of the
risk group cells under behaviour heading on the matrix
= 3 counts. For verification purposes, search findings
were checked against publications identified by Mimas
Zetoc Alert Service for HIV prevention articles. The
project lead was responsible for all coding of records,
thereby not requiring inter-observer variation checks,
however, quality assurance was conducted by a second
team member taking random samples from each data-
base to validate against our criteria.
Population of the matrix
Coded records were exported from Reference Manager
to the matrix in an Excel spreadsheet which contained
formulas for placing and counting the codes in corre-
sponding cells within the matrix. Each cell was subdi-
vided by study type, each column and row was totalled
and each area with no research was left blank for easy
visibility.
Results
Publication search results, coding and quality assurance
From 1995 to March 2009 NIHR, HTA received 80 sug-
gestions and proposals relating to HIV prevention. Out
of the 80 suggestions five were prioritised and research
subsequently funded. Publications were evident for two
of the five studies although one of these was excluded
d u et ob e i n go u t s i d et h ei n c l u s i o nd a t er a n g e2 0 0 6 - 9
(the other studies are still ongoing). The one remaining
included study was a systematic review on post-expo-
sure prophylaxis (PEP)[12].
From electronic database searches we identified 1648
publications across the three research design groups. 40
were excluded in the initial screening for duplications.
Through Mimas Zetoc Alert Service for HIV prevention
articles two additional articles were found and added to
our databases. A total of 1610 international publications
were suitable for further analysis (Table 1). These stu-
dies were rigorously screened, coded and counted
against inclusion criteria. Many publications focused on
more than one risk group and were counted again. A
second team member conducted quality assurance on
coding: random samples from each database (n = 206)
were checked: n = 8 errors were found (3.9%): two
coded incorrectly and six required an additional code to
one already given. 716 studies have 1 risk group; 127
s t u d i e s-2r i s kg r o u p s ;2 5s t u d i e s-3r i s kg r o u p s=
Total counts 868 (see full bibliography of included stu-
dies in Additional File 3).
Population of the matrix
After verification, the scores of the included studies
were exported to the appropriate cells in the matrix.
First impressions from the high numbers of studies
identified suggest that HIV prevention is generally a
heavily researched area, however, the results shown in
the matrix draw attention to some unexpected exclu-
sions within this field. The dense, sparse and empty
areas of research are visually evident within HIV preven-
tion activities, risk groups and study types - See the
matrix in Figure 1and areas for prioritisation below.
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replicated in other prevention areas such as obesity by:
a) defining headings for the matrix, b) search literature,
c) code publications and export to matrix.
Areas for prioritisation from the matrix findings
The matrix has highlighted several important areas
within HIV prevention research that represent potential
for novel and innovative research of interest to practi-
tioners, commissioners, policy makers and researchers
alike. We detail below those evidence gaps we believe
would be most useful for future research in HIV
prevention:
Sero-sorting: identifying the undiagnosed population
The Health Protection Agency (HPA) 2010 report shows
over a quarter of people who are HIV+ve are not aware of
their status[4]. Our analysis showed only four papers[13-16]
investigating this area, all of which examine sero-status
awareness and undiagnosed infection amongst gay men or
undefined populations. A difficulty with sero-sorting is pos-
sible overlap with testing issues, which, for the purposes of
this study, have a different focus - Additional file 1.
Table 1 A summary of numbers of excluded and included publications.
Designs Total identified Excluded Included (of which UK) Total matrix counts
Systematic Reviews 538 402 136 (20 incl. 1 HTA) 150
RCTs 461 200 261 (8) 322
Other Primary research 611 292 319 (28) 396
Totals 1610 894 716 (56) 868
Papers focusing on more than one risk group achieved multiple counts. Inclusions and coding were based on stringent criteria.
PreventionÂ
Risk GroupsÄ
Education (incl 
school and media) Behaviour
Law / Ethics 
/ Policy
Service 
delivery
Testing / 
Screening
Sero-sorting
Transmission & 
interaction with other 
infections
Intervention 
technologies
Descriptive 
Epidemiology
Social Factors / 
Popn level interv
Combination 
prevention 
packages
International 
adaptability 
research
Other Total
91 4 4 6 1
5
14 1 5 2 4 2 24 1 1 1 3
1 3 1
16 2
11 1 1 3 3 1 1 5 1 1
19 11 1
1
9 12 1 4 1 2
11 11
1 1
21 1 19 1 1 4
13 22 2 1 1 9 1 1 1 1 1
1
31 3 1 7 3 1 1 9
1
4 16
11 3
11 1 26 1 1
12
13 2 2 3 1 01 1 2
2 2
1
1 22 3
13 3 7 5 1
43 2 1
15 2 2 1 18 25 4 2 1
1
3
11
11 6
3 12 1 1
1 21
13 2 1 8
38 17 1 11 99 7 2 5
11 1 2 1 2
7 31 1
1
42 1 8 1 1
25 1 9 4 2 0 41 1 2
22 1
71 0 1 2 2 7 2 4 4 4 2 1 2
Totals 28 206 3 35 73 4 542 1 6 1622 5 10 3 49 868
Gay men / MSM
Scores of HIV prevention publications:
elements of prevention, risk groups and study designs
Other Primary = 319
Secondary = 135
RCTs = 261 THE MATRIX
716 studies have 1 risk group; 127 studies - 2 risk groups;  25 studies - 3 risk groups. Total scores 868. 
Antenatal / MCT
African/Black
Other Ethnic 
groups
Young People / 
Adolesc
Other age 
groups
Male
Female
Heterosexuals
Drug and 
alcohol Users
Transgender
HIV positive / 
sero-discord 
couples
Other vulnerable 
people
Sex workers
Socially 
excluded
Any other risk 
group / 
Undefined
51
43
26
83
1
16
50
88
13
109
30
129
4
10
27
188
Figure 1 The Matrix. This is the tool devised to map HIV prevention evidence published 2006-9
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the majority of HIV prevention research originates from
USA yet the matrix identified just three publications
[17-19] on research to test possible cultural translation
and adaptation for use in other countries. Two of these
studies examined the difficulties of adaptation, but the
third adapted a successful intervention from USA in
London and has since been adopted UK wide. Gay men
and young people were the only risk groups addressed
here.
Law/ethics/policy
We searched for studies investigating the effects of
interventions such as prosecutions and policies regard-
ing confidentiality, mortgages, travel restrictions and
ethics on HIV prevention. Three publications[20-22]
were identified addressing sex workers, ethnic minorities
and undefined risk groups. Admittedly, this is an area
where study design may present some difficulties. All
identified studies examined the impact of public policy
initiatives.
Combination packages of interventions
Limited HIV prevention resources could be optimised
through synergy. We identified ten publications addres-
sing this area. The majority of these were systematic
reviews that analysed more than one intervention. Only
two[23,24] of these studies aimed to examine the value
of combining levels of approaches.
Social/population level factors
Relative to other areas of prevention social factors are
revealed to be researched in moderation; 25 studies
were identified. These studies examine factors such as
gender, race, housing, poverty; only two[25,26] of these
i n v e s t i g a t es t i g m aa n dd i s c rimination from the health
provider perspective or the epidemic as a whole.
Education
The matrix also revealed fewer than anticipated studies
in this area of prevention. The matrix found 28 counts
in this area, the majority of which focused on impact of
traditional school education, leaflets and videos: small
group or individual exposure. Surprisingly, there were
only two publications[27,28] on the effectiveness of HIV
mass-media campaigns.
Risk groups
Interestingly, the matrix has illustrated some least tar-
geted but potentially emerging risk groups. These
include older age groups, transgender, sex workers,
male, heterosexuals, other ethnic (besides black/African),
socially excluded and other vulnerable risk groups. Our
findings indicate that risk groups such as HIV positive,
drug and alcohol users, Men who have sex with men
and young people are the most targeted groups for
study sample populations. However, examining the qual-
ity of these studies went beyond the scope of the cur-
rent research.
Discussion
Principle findings
To our knowledge this is the first study to identify
research gaps in HIV prevention using this novel method.
In order to develop the matrix, we created a classification
of prevention related activities and risk groups; a novel
building block of the study as called for by Akers in 2003
[29]. The development of the matrix has provided a tool
which we believe has potential transferability for scoping
other disease prevention areas such as obesity or type II
diabetes; which we hope will be investigated further. We
have identified six key under-researched prevention areas
(Table 2).
Limitations
There was no facility within the search strategy or
Reference Manager to identify multiple publications
from one study. A manual search of a quarter of the
database found 11 publications from 5 studies. As there
is no systematic way to identify multiplications or adjust
the matrix cells with certainty we could extrapolate
from this quarter sample and estimate that 44 papers
(out of 717 included) will come from 20 studies. How-
ever, in our conclusions we concentrate on the least
populated areas of the matrix (Table 2) and found no
multiple publications amongst them.
Publications that focused on more than one risk group
were problematic. By consensus the project team agreed
to repeat the count according to the risk groups
addressed. This appeared theo n l yw a yt of a i r l yr e p r e -
sent groups studied; however, this can cause confusion
when the counts of risk groups and prevention areas do
not match the numbers of publications identified. This
is an area for potential improvement.
The limited remit of this study did not enable us to
critically appraise beyond the hierarchy of evidence. In
heavily researched areas like behaviour change, the den-
sity of evidence does not necessarily equate to high
quality, robust research or provide evidence that trans-
lates to effective prevention. However, in the USA the
Centre for Disease Control have already set up a project
to synthesise evidence in relation to behavioural inter-
ventions: The Prevention Synthesis Project[31].
Conclusions
HIV prevention in the UK remains problematic; effec-
tiveness of current prevention efforts appears limited;
novel and innovative, evidence-based approaches are
needed in HIV prevention. HIV prevention remains one
of the great challenges for sexual health in the UK[32].
This study offers a method for identifying possible
future directions in research. This, in turn, may lead to
a more complete understanding of effective prevention
approaches.
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developed to identify important research gaps in HIV
prevention; both may be useful in other health areas.
Several important gaps in English language HIV pre-
vention research since 2006 were identified by the
matrix: identifying and understanding the undiagnosed
population; International adaptation of research; educa-
tion; intervention combinations. The key under-
researched risk groups were transgender, sex-workers,
heterosexuals and older age groups.
Three additional future research recommendations
have been identified during this study: investigate further
use of the classification system we have developed and
transferability of the matrix to other health prevention
areas; evidence syntheses may be appropriate in areas
dense with research, if not already being carried out by
CDC Prevention Research Synthesis Project (Behaviour);
have studies with positive findings have been translated
to practice and how many recommending future research
have been follow-up with funded studies?
The authors of this study invite research suggestions
relating to the evidence gaps identified within remits of
Public Health or any appropriate NETSCC programme.
Follow the ‘Suggest’ research links from:
http://www.netscc.ac.uk/. Enter - HIVProject -i n
optional ID for HTA or in first information box for
other programmes.
Additional material
Additional file 1: Definitions of risk groups and elements of
prevention. The file explains the working definitions for this study
Additional file 2: Search strategy. The full search strategy conducted
by Alison Price, information specialist
Table 2 Areas of HIV prevention research for prioritisation as identified by the matrix
Prevention Area Research published
2006-9
Why Important?
Sero-sorting: identifying and
understanding the undiagnosed
population
4 secondary research This population could have major implications as a source of new infections. We
suggest research in the area of sero-sorting could help learn more about people
within the undiagnosed population beyond the limits of current HPA unlinked
anonymous surveillance, which may underestimate undiagnosed figures e.g. a
recent community testing study in Scotland found 41.7% undiagnosed HIV[16].
Increasing testing facilities does not necessarily help someone recognise their
need to test or overcome fears of testing.
International adaptation research 1 RCT 2 secondary
research
More research here would be in the interests of shared learning and reduced
duplication across many countries, not just USA and UK. Only One of three
studies identified in this area points out that an HIV prevention intervention
found to be effective in US cities might not be generalisable to different times
and settings[17]. This area of research has great potential for the UK and the
international community.
Law/ethics/policy 3 secondary research The small number of studies found in this area was unexpected since a
government white paper in 1998 attempted to update the Offences Against the
Person Act 1861 and several prosecutions were successful in early 2000’s. All the
factors under this heading have potential to affect stigma and discrimination,
barriers to testing and reluctance to disclose HIV status and are therefore
potentially valuable areas for investigation.
Combination packages of interventions 3 RCTs 7 secondary
research
If a person’s reasons for being at risk are multi-faceted, interventions could be
also. A recent article in the Lancet concludes: We now require an urgent and
revitalised global movement for HIV prevention that supports a combination of
behavioural, structural, and biomedical approaches and is based on scientifically
derived evidence[3]. Potential to maximise impact through combining
interventions was a reiterated message at the 2009 International Society for STD
Research Conference; a sparsely researched area so far.
Social/population level factors 5 RCTs 5 other primary
11 secondary research
Recognition that social, economic, political, and environmental factors directly
affect HIV risk and vulnerability has stimulated interest in structural approaches to
HIV prevention[3,30]. Further investigation of factors such as stigma,
discrimination and poverty could add valuable new knowledge and aid design of
effective prevention strategies.
Education 18 RCTs 10 secondary
research
Education can be employed in many different ways and settings, as a starting
point for raising awareness, understanding transmission, how to protect against
infection and reducing fear. It was sometimes difficult to separate education from
behavioural interventions as one seeks to affect the other; we were guided by
how studies described their interventions and what outcomes were used. More
research in educational intervention could be valuable.
Akers[29] suggests that a nationally standardized HIV prevention intervention classification taxonomy would aid consistency and scientific validation across HIV
intervention studies. A small number of external experts and our study team have developed a novel taxonomy; further development may improve this, buti ti s
our opinion that we have contributed a promising start to providing a classification system.
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codes of all 716 studies found in searches.
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